Uraki, Ryuta http://orcid.org/0000-0003-0890-1922
Iida, Shun http://orcid.org/0000-0003-2258-9031
Halfmann, Peter J.
Yamayoshi, Seiya http://orcid.org/0000-0001-7768-5157
Hirata, Yuichiro
Iwatsuki-Horimoto, Kiyoko http://orcid.org/0000-0002-8266-020X
Kiso, Maki
Ito, Mutsumi
Furusawa, Yuri
Ueki, Hiroshi http://orcid.org/0000-0002-6557-0771
Sakai-Tagawa, Yuko
Kuroda, Makoto
Maemura, Tadashi
Kim, Taksoo
Mine, Sohtaro
Iwamoto, Noriko
Li, Rong
Liu, Yanan
Larson, Deanna
Fukushi, Shuetsu
Watanabe, Shinji
Maeda, Ken http://orcid.org/0000-0002-3488-5439
Wang, Zhongde http://orcid.org/0000-0003-2441-4729
Ohmagari, Norio
Theiler, James
Fischer, Will http://orcid.org/0000-0003-4579-4062
Korber, Bette http://orcid.org/0000-0002-2026-5757
Imai, Masaki http://orcid.org/0000-0001-6988-1975
Suzuki, Tadaki http://orcid.org/0000-0002-3820-9542
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21fk0108615, JP22fk0108637, JP22wm0125008, JP21fk0108552, JP22wm0125002, JP223fa627001)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (75N93021C00014)
Article History
Received: 2 September 2022
Accepted: 27 February 2023
First Online: 23 March 2023
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. The remaining authors declare that they have no competing interests.